ScreenerHero

UPC Universe Pharmaceuticals INC

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · universe-pharmacy.com
4.180USD-2.90%Mkt Cap: 21.00M $P/E: —

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the t…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap21.00M USD
Enterprise Value-17.12M USD
Revenue (TTM)17.74M USD
Gross Profit6.30M USD
Net Income (TTM)-3.67M USD
Revenue/Share31.48 USD
Last Price4.180 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees216
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA10.63
EV/Revenue-0.97
P/S1.19
P/B0.04
EPS (TTM)-1.38
EPS (Forward)—
52W Range
2.00014% of range17.96
52W High17.96 USD
52W Low2.000 USD
Profitability
Gross Margin35.28%
Oper. Margin-16.60%
EBITDA Margin-9.08%
Profit Margin-20.56%
ROE-6.54%
ROA-5.30%
Growth
Revenue Growth-1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.05M USD
CapEx (TTM)347.19K USD
FCF Margin-120.81%
FCF Yield-102.06%
Net Debt-19.50M USD
Net Debt/EBITDA12.11
Balance Sheet
Debt/Equity0.16
Current Ratio4.05
Quick Ratio3.25
Book Value/Sh98.78 USD
Cash/Share51.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateMar 24, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.01M
Float62.77K
Insiders88.82%
Institutions2.25%
Short Interest
Short Ratio0.2d
Short % Float1.52%
Short % Out.1.51%
Shares Short75.84K
Short (prev mo.)35.40K
Technical
SMA 504.874 (-14.2%)
SMA 2003.871 (+8.0%)
Beta1.68
S&P 52W Chg15.78%
Avg Vol (30d)187.43K
Avg Vol (10d)60.76K
Technical Indicators
RSI (14)43.5
MACD-0.1510
MACD Signal-0.1298
MACD Hist.-0.0212
BB Upper4.983 USD
BB Middle4.450 USD
BB Lower3.916 USD
BB Width24.00%
ATR (14)0.4795 USD
Vol Ratio (20d)0.20x